Semax 30mg — Vial Spec, Reconstitution Math & COA

Overview of the Semax 30mg Research Format

A 30mg vial of lyophilized Semax provides 30 milligrams of highly purified synthetic peptide mass, typically packaged in a standard 10mL tubular glass vial sealed under vacuum or inert nitrogen flush. This large-mass format is primarily selected by research laboratories conducting high-throughput screening, multi-plate in vitro cell culture assays, or extended preclinical animal model series where batch consistency across multiple experiment arms is critical. Ordering a single 30mg vial minimizes lot-to-lot variance that could otherwise introduce confounding variables when executing longitudinal neurobiology research.

At PX1 Research, we offer the Semax 30mg format alongside a comprehensive inventory of all peptides to support diverse experimental scales. If a specific research project requires custom fill volumes or continuous high-volume supply, our laboratory support team provides streamlined access to dedicated mass allocations.

Molecular Profile and Chemical Structure of Semax

Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-10), specifically structuralized as Met-Glu-His-Phe-Pro-Gly-Pro. By appending a Pro-Gly-Pro tripeptide sequence to the C-terminus of the ACTH(4-10) core, researchers improved metabolic stability against proteolytic cleavage while maintaining biological interaction with central nervous system targets in experimental models.

Preclinical investigations focus heavily on how this structural modification alters enzymatic degradation rates compared to endogenous peptides. Researchers utilizing research peptides in neurobiology examine Semax for its non-hormonal activity profile; despite its ACTH lineage, the peptide exhibits no corticosteroidogenic activity in animal models.

Precision Reconstitution Calculations for 30mg Lyophilized Vials

Accurately reconstituting a high-mass vial such as Semax 30mg requires calculating final peptide concentration based on added diluent volume. Utilizing our interactive reconstitution calculator, researchers can establish precise volumetric working solutions depending on target assay sensitivity:

1.0 mL Diluent: Yields a final concentration of 30.0 mg/mL (30.0 µg/µL). This high-density solution is optimal for micro-injection models or high-concentration stock preparation where minimal fluid volume is mandatory.

2.0 mL Diluent: Yields a final concentration of 15.0 mg/mL (15.0 µg/µL). This mid-range dilution allows accurate pipetting with standard low-volume displacement micropipettes (e.g., P20 or P200) for cellular incubation assays.

3.0 mL Diluent: Yields a final concentration of 10.0 mg/mL (10.0 µg/µL). This baseline concentration simplifies volumetric division (10 µL = 100 µg), facilitating rapid dosing calculations in rodent models.

Aliquot Strategy and Laboratory Storage Protocols

Due to the high mass content of a 30mg vial, repeated freeze-thaw cycles of reconstituted liquid can lead to peptide aggregation, peptide bond cleavage, or loss of biological efficacy in working assays. Laboratory protocols strongly recommend sub-aliquoting immediately following full dissolution.

Once reconstituted, the solution should be partitioned into sterile microcentrifuge tubes in single-use volumes (e.g., 50 µL to 200 µL) inside a laminar flow hood. Lyophilized powder stored at -20°C remains stable for up to 24 months, whereas reconstituted liquid aliquots stored at -80°C maintain structural integrity for extended research timelines. Storing reconstituted aliquots in frost-free freezers should be avoided due to temperature fluctuations during automatic defrost cycles.

Lot-Matched Certificate of Analysis (COA) Verification

High-throughput research demands rigorous verification of peptide purity, identity, and safety metrics. Every batch of Semax synthesized for PX1 Research undergoes stringent third-party testing at an ISO 17025 accredited laboratory. Researchers can access fully transparent, lot-matched documentation via our dedicated COA verification hub.

Standard analytical verification protocols include High-Performance Liquid Chromatography (HPLC) to confirm peptide purity exceeds 98.0%, Mass Spectrometry (MS) to verify theoretical molecular weight (810.9 g/mol), and chromogenic LAL assays to ensure endotoxin levels remain well under strict laboratory thresholds (<0.05 EU/mg).

Comparative Analysis: Semax vs. Related Research Neuropeptides

When establishing experimental controls within neuropeptide studies, researchers frequently compare Semax against structurally distinct or derivative research compounds. For example, Selank 10mg offers a synthetic analog of the endogenous tetrapeptide tuftsin, often studied in parallel for its contrasting immunomodulatory and anxiolytic receptor dynamics in rodent models. Alternatively, modified variants such as N-Acetyl Semax Amidate introduce N-terminal acetylation and C-terminal amidation to investigate heightened enzymatic resistance and altered blood-brain barrier permeability parameters. Furthermore, non-neurological comparative benchmarks such as Epitalon 10mg are frequently analyzed alongside neuropeptides to contrast central nervous system expression patterns against pineal and telomeric pathways in vitro.

Preclinical Biological Mechanisms and Target Pathways

In vitro assays and rodent studies indicate that Semax modulates key neurotrophic pathways. Preclinical research demonstrates that exposure to Semax elevates brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) mRNA expression within rat hippocampal and frontal cortex tissues.

Additionally, in vitro models of hypoxia show that Semax treatment influences vascular endothelial growth factor (VEGF) signaling and downregulates inflammatory cytokine cascades. These mechanisms make the peptide a central candidate in preclinical investigations exploring neuroprotection, synaptic plasticity, and ischemic tissue response.

Selecting Vial Size: 30mg vs. Standard Mass Options

Deciding between a high-capacity 30mg vial and smaller standard masses (such as 5mg or 10mg) depends on experimental scope. A 30mg vial is ideal for high-density assay screening, automated liquid handling platforms, or long-term multi-animal cohort studies requiring consistent reagent sourcing from a single synthesis batch.

Conversely, smaller vial sizes are preferable for short-term pilot studies, proof-of-concept assays, or applications where diluent instability over time poses a risk. For large-scale university laboratories or institutional facilities running parallel trials, exploring our wholesale lab program allows custom batching and consistent volume allocation across projects.

Handling Diluents and Solvent Compatibility

Proper reconstitution of Semax requires selecting an appropriate solvent system based on experimental targets. Bacteriostatic water (0.9% benzyl alcohol) is typically utilized when reconstituted aliquots are drawn over several days to prevent microbial contamination.

For sensitive cell culture systems or in vitro electrophysiology where benzyl alcohol might interfere with cellular ion channels, sterile 0.9% Sodium Chloride Injection, USP, or phosphate-buffered saline (PBS) is recommended. Care must be taken not to vortex high-concentration peptide solutions vigorously; gentle manual inversion ensures complete dissolution without mechanical shear stress.

PX1 Research Quality Assurance & USA Manufacturing Standards

PX1 Research adheres to uncompromising quality standards. All research peptides are manufactured in USA-based, GMP-compliant facilities under strict quality management systems. By pairing state-of-the-art synthesis with independent verification, PX1 ensures that every vial delivers exact mass accuracy, minimal residual moisture, and zero unwanted impurities.

Our fast fulfillment operations from California and Arizona ensure rapid transit to maintain product stability for research teams nationwide. Every shipment includes clear lot labeling to match analytical documentation directly to your lab's inventory system.